Maresin 1 protects the liver against ischemia/reperfusion injury via the ALXR/Akt signaling pathway.
Da TangGuang FuWenbo LiPing SunPatricia A LoughranMeihong DengMelanie J ScottTimothy R BilliarPublished in: Molecular medicine (Cambridge, Mass.) (2021)
MaR1 protects the liver against hepatic I/R injury via an ALXR/Akt signaling pathway. MaR1 may represent a novel therapeutic agent to mitigate the detrimental effects of I/R-induced liver injury.